Literature DB >> 20732341

Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism.

Mohamed A M El Gendy1, Ayman O S El-Kadi.   

Abstract

Harman is a common compound in several foods, plants and beverages. Numerous studies have demonstrated its mutagenic, co-mutagenic and carcinogenic effects; however, the exact mechanism has not been fully identified. Aryl hydrocarbon receptor (AhR) is a transcription factor regulating the expression of the carcinogen-activating enzyme; cytochrome P450 1A1 (CYP1A1). In the present study, we examined the ability of harman to induce AhR-mediated signal transduction in human and rat hepatoma cells; HepG2 and H4IIE cells. Our results showed that harman significantly induced CYP1A1 mRNA in a time- and concentration-dependent manner. Similarly, harman significantly induced CYP1A1 at protein and activity levels in a concentration-dependent manner. Moreover, the AhR antagonist, resveratrol, inhibited the increase in CYP1A1 activity by harman. The RNA polymerase inhibitor, actinomycin D, completely abolished the CYP1A1 mRNA induction by harman, indicating a transcriptional activation. The role of AhR in CYP1A1 induction by harman was confirmed by using siRNA specific for human AhR. The ability of harman to induce CYP1A1 was strongly correlated with its ability to stimulate AhR-dependent luciferase activity and electrophoretic mobility shift assay. At post-transcriptional and post-translational levels, harman did not affect the stability of CYP1A1 at the mRNA and the protein levels, excluding other mechanisms participating in the obtained effects. We concluded that harman can directly induce CYP1A1 gene expression in an AhR-dependent manner and may represent a novel mechanism by which harman promotes mutagenicity, co-mutagenicity and carcinogenicity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732341     DOI: 10.1016/j.taap.2010.08.014

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Toxicol Lett       Date:  2011-10-06       Impact factor: 4.372

2.  The p38 MAPK inhibitor SB203580 induces cytochrome P450 1A1 gene expression in murine and human hepatoma cell lines through ligand-dependent aryl hydrocarbon receptor activation.

Authors:  Hesham M Korashy; Anwar Anwar-Mohamed; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Chem Res Toxicol       Date:  2011-07-27       Impact factor: 3.739

3.  Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Food Chem Toxicol       Date:  2011-10-21       Impact factor: 6.023

4.  Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin.

Authors:  Dea Shahinas; Gregory Macmullin; Christan Benedict; Ian Crandall; Dylan R Pillai
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

5.  Sinomenine induces the generation of intestinal Treg cells and attenuates arthritis via activation of aryl hydrocarbon receptor.

Authors:  Bei Tong; Xusheng Yuan; Yannong Dou; Xin Wu; Yuhui Wang; Yufeng Xia; Yue Dai
Journal:  Lab Invest       Date:  2016-09-12       Impact factor: 5.662

6.  A network model for angiogenesis in ovarian cancer.

Authors:  Kimberly Glass; John Quackenbush; Dimitrios Spentzos; Benjamin Haibe-Kains; Guo-Cheng Yuan
Journal:  BMC Bioinformatics       Date:  2015-04-11       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.